Synapse - Works

Results (115370)

Assessment of an emergency 14-day (d) integrative supportive care program (14-EISCP) followed by early chemotherapy (CTx) in symptomatic patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): A prospective ARCAD cohort study

Meeting Abstract

Rousseau, B.; Falcoz, A.; Toullec, C.; Lecomte, T.; Lambert, A.; Tournigand, C.; Guerin-Meyer, V.; Louvet, C.; Trouilloud, I.; Rinaldi, Y.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO)

Meeting Abstract

Keane, F.; Balogun, F.; O'Connor, C.; Crowley, F.; Chan, A.; Cowzer, D.; Chou, J. F.; Park, W.; Varghese, A. M.; Yu, K. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase II trial of maximal ablative irradiation because of encasement (MAIBE) for patients with potentially resectable locally advanced pancreatic cancer

Meeting Abstract

Reyngold, M.; Wei, A.; O'Reilly, E. M.; D'Angelica, M. I.; Drebin, J. A.; Soares, K.; Kingham, T. P.; Balachandran, V. P.; Varghese, A. M.; Park, W.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)

Meeting Abstract

Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome

Meeting Abstract

Song, Y.; Boerner, T.; Drill, E. N.; Shin, P.; Cercek, A.; Kemeny, N. E.; Abou-Alfa, G. K.; Iacobuzio-Donahue, C. A.; Schultz, N.; Walch, H. S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing

Meeting Abstract

McIntyre, S. M. H.; Preston, W.; Walch, H. S.; Sigel, C. S.; Sharib, J.; Chen, W.; Lidsky, M.; Kundra, R.; Cercek, A.; Harding, J. J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy and safety of erdafitinib in adults with cholangiocarcinoma (CCA) with prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase 2 open-label, single-arm RAGNAR trial: Expansion cohort results

Meeting Abstract

Pant, S.; Schuler, M. H.; Iyer, G.; Doi, T.; Qin, S.; Tabernero, J.; Arnold, D.; Gutierrez, M.; Prenen, H.; Folprecht, G.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Presence and impact of antidrug antibodies (ADAs) to tremelimumab (T) or durvalumab (D) in the phase 3 HIMALAYA study of unresectable hepatocellular carcinoma (uHCC)

Meeting Abstract

Crysler, O. V.; Yarchoan, M.; Furuse, J.; Galle, P. R.; Sukeepaisarnjaroen, W.; Thinh, N. T.; Masi, G.; Lim, H. Y.; Varela, M.; Gupta, C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage

Meeting Abstract

Sharib, J.; Liu, A.; McIntyre, S. M. H.; Rhodin, K. E.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; Abou-Alfa, G. K.; Soares, K.; Wei, A. C. C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy and safety of the MDM2–p53 antagonist BI 907828 in patients with advanced biliary tract cancer: Data from two phase Ia/Ib dose-escalation/expansion trials

Meeting Abstract

Yamamoto, N.; Tolcher, A. W.; Hafez, N.; Lugowska, I.; Ramlau, R.; Gounder, M. M.; Geng, J.; Li, J.; Teufel, M.; Maerten, A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save